X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Orchid Chemicals with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs ABBOTT INDIA - Comparison Results

ORCHID PHARMA LTD    Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA LTD ABBOTT INDIA ORCHID PHARMA LTD/
ABBOTT INDIA
 
P/E (TTM) x 0.1 35.1 0.4% View Chart
P/BV x 0.2 10.2 1.7% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 ORCHID PHARMA LTD   ABBOTT INDIA
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
ABBOTT INDIA
Mar-17
ORCHID PHARMA LTD/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs1945,190 3.7%   
Low Rs354,351 0.8%   
Sales per share (Unadj.) Rs276.51,382.9 20.0%  
Earnings per share (Unadj.) Rs-79.2130.2 -60.8%  
Cash flow per share (Unadj.) Rs-43.5137.9 -31.5%  
Dividends per share (Unadj.) Rs040.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs53.9652.7 8.3%  
Shares outstanding (eoy) m70.4521.25 331.5%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.43.4 12.0%   
Avg P/E ratio x-1.436.6 -3.9%  
P/CF ratio (eoy) x-2.634.6 -7.6%  
Price / Book Value ratio x2.17.3 29.0%  
Dividend payout %030.7 0.0%   
Avg Mkt Cap Rs m8,067101,373 8.0%   
No. of employees `0002.83.1 90.8%   
Total wages/salary Rs m2,5273,453 73.2%   
Avg. sales/employee Rs Th6,956.19,531.9 73.0%   
Avg. wages/employee Rs Th902.51,119.9 80.6%   
Avg. net profit/employee Rs Th-1,993.0897.3 -222.1%   
INCOME DATA
Net Sales Rs m19,47729,387 66.3%  
Other income Rs m407576 70.6%   
Total revenues Rs m19,88429,963 66.4%   
Gross profit Rs m1,1033,973 27.8%  
Depreciation Rs m2,519164 1,533.3%   
Interest Rs m5,22720 25,621.6%   
Profit before tax Rs m-6,2364,365 -142.9%   
Minority Interest Rs m200-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m5110-   
Tax Rs m-1251,598 -7.8%   
Profit after tax Rs m-5,5802,767 -201.7%  
Gross profit margin %5.713.5 41.9%  
Effective tax rate %2.036.6 5.5%   
Net profit margin %-28.79.4 -304.3%  
BALANCE SHEET DATA
Current assets Rs m11,01418,906 58.3%   
Current liabilities Rs m32,0606,297 509.2%   
Net working cap to sales %-108.142.9 -251.8%  
Current ratio x0.33.0 11.4%  
Inventory Days Days9562 152.6%  
Debtors Days Days3422 155.1%  
Net fixed assets Rs m29,4401,159 2,540.6%   
Share capital Rs m705213 331.5%   
"Free" reserves Rs m2,04313,657 15.0%   
Net worth Rs m3,80013,869 27.4%   
Long term debt Rs m9,0180-   
Total assets Rs m46,51020,638 225.4%  
Interest coverage x-0.2215.0 -0.1%   
Debt to equity ratio x2.40-  
Sales to assets ratio x0.41.4 29.4%   
Return on assets %-0.813.5 -5.6%  
Return on equity %-146.919.9 -736.2%  
Return on capital %-3.731.6 -11.8%  
Exports to sales %37.90-   
Imports to sales %22.60-   
Exports (fob) Rs m7,378NA-   
Imports (cif) Rs m4,406NA-   
Fx inflow Rs m7,5130-   
Fx outflow Rs m5,6490-   
Net fx Rs m1,8650-   
CASH FLOW
From Operations Rs m1,6823,072 54.7%  
From Investments Rs m-9,860-1,554 634.5%  
From Financial Activity Rs m6,644-898 -740.2%  
Net Cashflow Rs m-1,535621 -247.4%  

Share Holding

Indian Promoters % 32.3 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 4.6 7.9 58.2%  
FIIs % 3.3 0.1 3,300.0%  
ADR/GDR % 4.6 0.0 -  
Free float % 55.3 17.1 323.4%  
Shareholders   84,811 18,270 464.2%  
Pledged promoter(s) holding % 54.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA LTD With:   PIRAMAL ENTERPRISES  NOVARTIS  PANACEA BIOTECH  DR. REDDYS LAB  GSK PHARMA  

Compare ORCHID PHARMA LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 262 Points Up; ONGC & Tata Steel Top Gainers(Closing)

Indian share markets ended the day on a strong note. At the closing bell, the BSE Sensex finished higher by 262 points. While, the NSE Nifty finished up by 91 points.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Beware the 5th year of the Modi Regime(The Honest Truth)

May 22, 2018

2017 was a great year for the market. You were rewarded for taking excessive risk. But Ajit Dayal believes 2018 will be different. You will be rewarded for doing the opposite. Read on to know more...

Beware of Inflated Stock Market Angels(Sector Info)

May 17, 2018

The stock of Vakrangee helps us understand why it's a bad idea to chase high-flying stocks.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


May 25, 2018 (Close)

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD 8-QTR ANALYSIS

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS